Gladius Capital Management’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-6,800
Closed -$659K 314
2023
Q3
$659K Sell
6,800
-4,300
-39% -$452K 0.03% 137
2023
Q2
$1.21M Buy
+11,100
New +$1.18M 0.06% 89
2021
Q2
Sell
-5,800
Closed -$696K 127
2021
Q1
$696K Hold
5,800
0.03% 142
2020
Q4
$636K Buy
5,800
+2,300
+66% +$250K 0.03% 151
2020
Q3
$381K Buy
+3,500
New +$355K 0.04% 137
2020
Q2
Sell
-11,400
Closed -$900K 13
2020
Q1
$900K Sell
11,400
-3,100
-21% -$259K 0.09% 96
2019
Q4
$1.26M Buy
14,500
+5,400
+59% +$452K 0.08% 121
2019
Q3
$762K Buy
+9,100
New +$773K 0.03% 167

Other funds holding ABT

Gladius Capital Management's ABT Position: Q3 2025 in Review

Gladius Capital Management sold out of Abbott (ABT) in Q3 2025, closing a stake of 808 shares — an estimated $110K sold.

Gladius Capital Management first reported a position in ABT in Q3 2019 and held it in 17 quarters. The position peaked at $1.97M in Q1 2023. 3,172 funds tracked by Wall St. Rank hold ABT as of Q3 2025.

  • Gladius Capital Management reported no remaining Abbott position as of Q3 2025 after selling out during the quarter.
  • Gladius Capital Management sold 808 Abbott shares in Q3 2025, an estimated $110K.
  • Gladius Capital Management first reported a position in Abbott in Q3 2019 and held it in 17 quarters.
  • Gladius Capital Management's Abbott position peaked at $1.97M in Q1 2023.
  • 3,172 funds tracked by Wall St. Rank held Abbott as of Q3 2025.

Based on Gladius Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.